Its expression in clinical breast cancer samples was not associated with the expression of the proliferation markers Ki‐67, Cyclin D1, or Rb, suggesting that WNT‐5A does not inhibit the proliferation of these tumors (Dejmek et al., 2005b). Here, WNT5A is linked to breast carcinoma.